billHR5498Event Wednesday, May 20, 2026Analyzed

Small Business Health Options Awareness Act of 2025

Neutral

Summary

H.R. 5498 is a procedural bill requiring the SBA to provide information on ICHRAs to small businesses. It authorizes no funding and creates no regulatory changes, resulting in negligible market impact.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.H.R. 5498 is an informational bill with no funding or policy changes.
  • 2.No publicly traded companies are directly affected.
  • 3.The bill remains in early legislative stages with uncertain passage.

Market Implications

No market implications. The bill does not alter any company's revenue, costs, or competitive position. Healthcare sector investors should ignore this legislation as a non-event.

Full Analysis

The Small Business Health Options Awareness Act of 2025 (H.R. 5498) was reported out of the House Small Business Committee on a party-line vote of 13-11 on May 20, 2026. The bill requires the SBA Administrator to disseminate information from federal agencies on individual coverage health reimbursement arrangements (ICHRAs) through small business development centers and SBA district offices, as well as via SBA communications channels. ICHRAs are existing regulatory constructs under IRS rules finalized in 2019. This legislation does not authorize any new spending, create tax incentives, or alter substantive law. It is purely an outreach/education mandate to raise awareness among small businesses about an existing benefit option. As such, there is no direct funding mechanism, no obligated party other than the SBA itself, and no change in the competitive or regulatory landscape for any healthcare sector company. The legislative path ahead requires floor consideration and Senate passage, but even if enacted, the material impact on publicly traded firms is zero. Investors should not expect any revenue or earnings effects from this bill.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.